Annual Revenue
$55.20 K
-$84.90 K-60.60%
December 31, 2023
Summary
- As of February 12, 2025, GANX annual revenue is $55.20 thousand, with the most recent change of -$84.90 thousand (-60.60%) on December 31, 2023.
- During the last 3 years, GANX annual revenue has risen by +$26.30 thousand (+91.00%).
- GANX annual revenue is now -66.55% below its all-time high of $165.00 thousand, reached on December 31, 2021.
Performance
GANX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- GANX quarterly revenue is not available.
Performance
GANX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- GANX TTM revenue is not available.
Performance
GANX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
GANX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.6% | - | - |
| 3 y3 years | +91.0% | - | - |
| 5 y5 years | +168.0% | - | - |
GANX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.5% | at low | ||||
| 5 y | 5-year | -66.5% | +91.0% | ||||
| alltime | all time | -66.5% | +168.0% |
Gain Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $55.20 K(-60.6%) | - | - |
| Mar 2023 | - | $55.20 K(-42.0%) | $150.30 K(-28.6%) |
| Dec 2022 | $140.10 K(-15.1%) | - | - |
| Jun 2022 | - | $95.10 K(+111.3%) | $210.60 K(+2.9%) |
| Mar 2022 | - | $45.00 K(+4.2%) | $204.70 K(+24.1%) |
| Dec 2021 | $165.00 K | - | - |
| Dec 2021 | - | $43.20 K(+58.2%) | $165.00 K(+26.1%) |
| Sep 2021 | - | $27.30 K(-69.4%) | $130.90 K(+18.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $89.20 K(+1583.0%) | $110.30 K(+301.1%) |
| Mar 2021 | - | $5300.00(-41.8%) | $27.50 K(-4.8%) |
| Dec 2020 | $28.90 K(-30.0%) | - | - |
| Dec 2020 | - | $9100.00(+35.8%) | $28.90 K(+46.0%) |
| Sep 2020 | - | $6700.00(+4.7%) | $19.80 K(+51.1%) |
| Jun 2020 | - | $6400.00(-4.5%) | $13.10 K(+95.5%) |
| Mar 2020 | - | $6700.00 | $6700.00 |
| Dec 2019 | $41.30 K(+100.5%) | - | - |
| Dec 2018 | $20.60 K | - | - |
FAQ
- What is Gain Therapeutics annual revenue?
- What is the all time high annual revenue for Gain Therapeutics?
- What is Gain Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Gain Therapeutics?
- What is the all time high TTM revenue for Gain Therapeutics?
What is Gain Therapeutics annual revenue?
The current annual revenue of GANX is $55.20 K
What is the all time high annual revenue for Gain Therapeutics?
Gain Therapeutics all-time high annual revenue is $165.00 K
What is Gain Therapeutics annual revenue year-on-year change?
Over the past year, GANX annual revenue has changed by -$84.90 K (-60.60%)
What is the all time high quarterly revenue for Gain Therapeutics?
Gain Therapeutics all-time high quarterly revenue is $95.10 K
What is the all time high TTM revenue for Gain Therapeutics?
Gain Therapeutics all-time high TTM revenue is $210.60 K